최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of Korean biological nursing science, v.19 no.1, 2017년, pp.38 - 47
Purpose: This study was undertaken to examine the relationship between airflow obstruction and subjective health status reported by stable patients with chronic obstructive pulmonary disease (COPD) residing in the community. Methods: A cross-sectional descriptive study was conducted with 78 stable C...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
만성폐쇄성폐질환의 치료의 결정과 효과 감시를 위한 주요 지표 중 폐의 기류제한의 정도는 무엇인가? | 특히, 질환의 중증도와 대상자가 경험하는 증상에 따라 적절한 치료를 하고 치료 효과와 대상자 예후의 지속적 감시가 강조되어 왔는데[3], 대상자의치료효과와 예후 측정을 위해 다양한 지표들이 사용 되어 왔다. 이중 만성적인 기도 폐쇄를 특징으로 하는 질환의 특성 상 COPD의 중증도 단계를 나누고 치료의 결정과 효과 감시를 위한 주요 지표로 폐의 기류제한(degree of airflow obstruction)의 정도가 중시되어왔는데[4], 폐활량계(spirometry)를 이용한 폐기능 검사결과 중 1초간 강제 호기량(Forced expiratory volume in 1 second, FEV1) 이 그것이다[5]. | |
만성폐쇄성폐질환이란 무엇인가? | 만성폐쇄성폐질환(Chronic obstructive pulmonary disease, COPD)은 오랜 기간에 걸쳐 점진적으로 악화되는 비가역적 질환으로[1] 증상이 악화되고 그 중증도 증가에 따라 과다 의료비용 지출의 원인이 될 수 있으므로 만성 질환이 중증이 되지 않도록 관리하는 체계적 노력과 효과적인 관리가 중요하다[2]. | |
COPD를 예방하는 방법은? | COPD 환자의 효과적 관리를 위해서는 약물요법과 비약물 요법을 병행하여[3] 호흡곤란 등의 증상 완화와 일상생활 등 활동성 유지에 초점을 두어 대상자의 신체적, 사회적 기능수행과 자율성을최적화하고 급격한 악화를 예방하여야 한다[1]. 특히, 질환의 중증도와 대상자가 경험하는 증상에 따라 적절한 치료를 하고 치료 효과와 대상자 예후의 지속적 감시가 강조되어 왔는데[3], 대상자의치료효과와 예후 측정을 위해 다양한 지표들이 사용 되어 왔다. |
Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. American Journal of Respiratory and Critical Care Medicine. 2006;173(12):1390-1413. http://dx.doi.org/10.1164/rccm.200508-1211ST
Yoon HS. Health insurance policies preparing the aging society. KDI Economic trend, 2013;2:31-42.
Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American Journal of Respiratory and Critical Care Medicine. 2013;187(4):347-365. http://dx.doi.org/10.1164/rccm.201204-0596PP
Dijk WD, Bemt L, Haak-Rongen S, Bischoff E, Weel C, Veen JC, et al. Multidimensional prognostic indices for use in COPD patient care. A systematic review. Respiratory Research, 2011;12:151-161. http://dx.doi.org/10.1186/1465-9921-12-151
Esteban C, Quintana JM, Aburto M, Moraza J, Capelastegui A. A simple score for assessing stable chronic obstructive pulmonary disease. QJM : Monthly Journal of the Association of Physicians. 2006;99(11):751-759. http://dx.doi.org/10.1093/qjmed/hcl110
Van der Molen T, Diamant Z, Kocks JW, Tsiligianni IG. The use of health status questionnaires in the management of chronic obstructive pulmonary disease patients in clinical practice. Expert Review of Respiratory Medicine. 2014;8(4):479-491. http://dx.doi.org/10.1586/17476348.2014.918851
Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation:The St. George's Respiratory Questionnaire. The American Review of Respiratory Diseas., 1992;145(6):1321-1327. http://dx.doi.org/10.1164/ajrccm/145.6.1321
Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987;42(10):773-778. http://dx.doi.org/10.1136/thx.42.10.773
McGarvey L. Keeping up appearances: the importance of maintaining health status in COPD. Thorax. 2015;70(9):813-814. http://dx.doi.org/10.1136/thoraxjnl-2015-207355
Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. The European Respiratory Journal. 2009;34(3):648-654. http://dx.doi.org/10.1183/09031936.00102509
Silva GP, Morano MT, Viana CM, Magalhaes CB, Pereira ED. Portuguese-language version of the COPD Assessment Test: validation for use in Brazil. Jornal Brasileiro de Pneumologia. 2013;39(4):402-408. http://dx.doi.org/10.1590/S1806-37132013000400002
Kim S, Oh J, Kim YI, Ban HJ, Kwon YS, Oh IJ, et al. Differences in classification of COPD group using COPD assessment test (CAT) or modified Medical Research Council (mMRC) dyspnea scores: a cross-sectional analyses. BMC Pulmonary Medicine. 2013;13:35. http://dx.doi.org/10.1186/1471-2466-13-35
Lee CH, Ko SJ, Kwak NW, Kim JH, Bae W, Lee HY, et al. Comparison between chronic obstructive pulmonary disease assessment Test (CAT) and modified medical round council (mMRC) in COPD patients. Conference Proceeding of Korean Academy of Tuberculosis of Respiratory Disease. 2012;114(0):225.
Irwin DE, Atwood CA, Jr., Hays RD, Spritzer K, Liu H, Donohue JF, et al. Correlation of PROMIS scales and clinical measures among chronic obstructive pulmonary disease patients with and without exacerbations. Quality of Life Research. 2015;24(4):999-1009. http://dx.doi.org/10.1007/s11136-014-0818-1
Cohen J. Statistical power analysis for the behavior science. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associate; 1988.109-138.
Vercoulen JH, Daudey L, Molema J, Vos PJ, Peters JB, Top M, et al. An Integral assessment framework of health status in chronic obstructive pulmonary disease (COPD). International Journal of Behavioral Medicine. 2008;15(4):263-279. http://dx.doi.org/10.1080/10705500802365474
Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581-586. http://dx.doi.org/10.1136/thx.54.7.581
American Thoracic Society. Standardization of Spirometry, 1994 Update. American Journal of Respiratory and Critical Care Medicine. 1995;152(3): 1107-1136. http://dx.doi.org/10.1164/ajrccm.152.3.7663792
Jones PW. Health status and the spiral of decline. COPD. 2009;6(1):59-63. http://dx.doi.org/10.1080/15412550802587943
Agusti A, Soler-Cataluna JJ, Molina J, Morejon E, Garcia-Losa M, Roset M, et al. Does the COPD assessment test (CATTM) questionnaire produce similar results when self- or interviewer administered? Quality of Life Research. 2015;24(10):2345-2354. http://dx.doi.org/10.1007/s11136-015-0983-x
Wedzicha JA, Seemungal TA, MacCallum PK, Paul EA, Donaldson GC, Bhowmik A, et al. Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels. Thrombosis and Haemostasis. 2000;84(2):210-215.
Donaldson GC, Hurst JR, Smith CJ, Hubbard RB, Wedzicha JA. Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest. 2010;137(5):1091-1097. http://dx.doi.org/10.1378/chest.09-2029
Wilke S, Jones PW, Mullerova H, Vestbo J, Tal-Singer R, Franssen FM, et al. One-year change in health status and subsequent outcomes in COPD. Thorax. 2015;70(5):420-425. http://dx.doi.org/10.1136/thoraxjnl-2014-205697
Cunningham S, McMurray A. The availability and use of oxygen saturation monitoring in primary care in order to assess asthma severity. Primary Care Respiratory Journal. 2006;15(2):98-101. http://dx.doi.org/10.1016/j.pcrj.2006.01.005
Schermer T, Leenders J, in 't Veen H, van den Bosch W, Wissink A, Smeele I, et al. Pulse oximetry in family practice: indications and clinical observations in patients with COPD. Family Practice. 2009;26(6):524-531. http://dx.doi.org/10.1093/fampra/cmp063
Jensen LA, Onyskiw JE, Prasad NG. Meta-analysis of arterial oxygen saturation monitoring by pulse oximetry in adults. Heart & Lung. 1998;27(6):387-408.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.